Feasibility of Assisted-VATS(Video-Assisted Thoracoscopic Surgery) Sleeve Lobectomy for Non-small Cell Lung Cancer
Sleeve lobectomy is removal of a portion of a main stem bronchus in continuity with the
adjacent lobe or bilobe followed by end-to-end bronchial anastomosis. The first reported
bronchial sleeve resection was performed in 1947 at the Brompton Hospital in London,
England, by Sir Clement Price Thomas. Whether sleeve resection is radical enough and
indicated for patients who could tolerate pneumonectomy continues to be debated, although
many recent reports have suggested that sleeve resection can achieve adequate curability
rates. However, sleeve lobectomy has a definite role in the surgical management of lung
cancer for patients whose pulmonary reserve is considered inadequate to permit
pneumonectomy, and should be used anytime it is possible to achieve a margin-negative (R0)
resection.
Although video-assisted thoracic surgery (VATS) is regarded as a minimally invasive
procedure with good long-term survival results, many surgeons think that VATS is too complex
and has too many technical limitations to be applied to bronchoplasty. Therefore, there are
few reports in the literature of VATS bronchoplasty for lung cancer. The purpose of this
study is to examine the feasibility of assisted-VATS (video-assisted thoracoscopic surgery)
sleeve lobectomy for non-small cell lung cancer for non-small cell lung cancer. Success is
defined as assisted-VATS sleeve lobectomy without conversion. If success rate over 90%,
assisted-VATS sleeve lobectomy is considered as feasible procedures for non-small cell lung
cancer.
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
If success rate over 90%, assisted-VATS sleeve lobectomy is considered as feasible procedures for non-small cell lung cancer. (Success is defined as assisted-VATS sleeve lobectomy without conversion).
3 months
Yes
Jianxing He, MD,FACS
Study Director
Department of Cardiothoracic Surgery, the First Affiliated Hospital of Guangzhou Medical College
China: Food and Drug Administration
FAHG96016
NCT00997724
February 1996
January 2011
Name | Location |
---|